Selected research
Industry Growth & Trends
Global Digital Endocrine Disease Management Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Digital Endocrine Disease Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Digital Endocrine Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Digital Endocrine Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Digital Endocrine Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Digital Endocrine Disease Management market include Abbott Diabetes Care, Dexcom Inc, Vida Health, Welldoc, Lark Health, Roche Diabetes Care, Oviva AG, Kaia Health and CureApp Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Digital Endocrine Disease Management market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Digital Endocrine Disease Management market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Digital Endocrine Disease Management market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Digital Endocrine Disease Management.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Digital Endocrine Disease Management market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Digital Endocrine Disease Management Market by Company
Abbott Diabetes Care
Dexcom Inc
Vida Health
Welldoc
Lark Health
Roche Diabetes Care
Oviva AG
Kaia Health
CureApp Inc
Welby Inc
Ubie Inc
TeleMed2U
Twin Health
eddii-Care
DocVilla
Novo Nordisk Digital Health
Shangyi Technology
JD Health
Alibaba Health
Teladoc Health
Omada Health
Virta Health
Digital Endocrine Disease Management Segment by Type
Diabetes Management
Thyroid Disease Management
Obesity and Metabolic Disorder Management
PCOS Management
Osteoporosis Management
Others
Digital Endocrine Disease Management Segment by Application
Consumer Health
Chronic Disease Management
Hospital Digital Care
Employer Wellness
Others
Digital Endocrine Disease Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Endocrine Disease Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Endocrine Disease Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Endocrine Disease Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Digital Endocrine Disease Management companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Diabetes Management
- Thyroid Disease Management
- Obesity and Metabolic Disorder Management
- PCOS Management
- Osteoporosis Management
- Others
Applications
- Consumer Health
- Chronic Disease Management
- Hospital Digital Care
- Employer Wellness
- Others
Companies covered
- Abbott Diabetes Care
- Dexcom Inc
- Vida Health
- Welldoc
- Lark Health
- Roche Diabetes Care
- Oviva AG
- Kaia Health
- CureApp Inc
- Welby Inc
- Ubie Inc
- TeleMed2U
- Twin Health
- eddii-Care
- DocVilla
- Novo Nordisk Digital Health
- Shangyi Technology
- JD Health
- Alibaba Health
- Teladoc Health
- Omada Health
- Virta Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Digital Endocrine Disease Management Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Digital Endocrine Disease Management Market Size by Region (2021-2032)
- 1.4.1 Global Digital Endocrine Disease Management Market Size by Region (2021-2026)
- 1.4.2 Global Digital Endocrine Disease Management Market Size by Region (2027-2032)
- 1.5 Key Regions Digital Endocrine Disease Management Market Size (2021-2032)
- 1.5.1 North America Digital Endocrine Disease Management Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Digital Endocrine Disease Management Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Digital Endocrine Disease Management Market Size Growth Rate (2021-2032)
- 1.5.4 South America Digital Endocrine Disease Management Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Digital Endocrine Disease Management Market Size Growth Rate (2021-2032)
2 Digital Endocrine Disease Management Market by Type
- 2.1 Type Introduction
- 2.1.1 Diabetes Management
- 2.1.2 Thyroid Disease Management
- 2.1.3 Obesity and Metabolic Disorder Management
- 2.1.4 PCOS Management
- 2.1.5 Osteoporosis Management
- 2.1.6 Others
- 2.2 Global Digital Endocrine Disease Management Market Size by Type
- 2.2.1 Global Digital Endocrine Disease Management Market Size Overview by Type (2021-2032)
- 2.2.2 Global Digital Endocrine Disease Management Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Digital Endocrine Disease Management Market Size Forecasted by Type (2027-2032)
- 2.3 Global Digital Endocrine Disease Management Market Size by Regions
- 2.3.1 North America Digital Endocrine Disease Management Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Digital Endocrine Disease Management Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Digital Endocrine Disease Management Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Digital Endocrine Disease Management Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Digital Endocrine Disease Management Market Size Breakdown by Type (2021-2026)
3 Digital Endocrine Disease Management Market by Application
- 3.1 Type Introduction
- 3.1.1 Consumer Health
- 3.1.2 Chronic Disease Management
- 3.1.3 Hospital Digital Care
- 3.1.4 Employer Wellness
- 3.1.5 Others
- 3.2 Global Digital Endocrine Disease Management Market Size by Application
- 3.2.1 Global Digital Endocrine Disease Management Market Size Overview by Application (2021-2032)
- 3.2.2 Global Digital Endocrine Disease Management Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Digital Endocrine Disease Management Market Size Forecasted by Application (2027-2032)
- 3.3 Global Digital Endocrine Disease Management Market Size by Regions
- 3.3.1 North America Digital Endocrine Disease Management Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Digital Endocrine Disease Management Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Digital Endocrine Disease Management Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Digital Endocrine Disease Management Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Digital Endocrine Disease Management Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Digital Endocrine Disease Management Industry Trends
- 4.2 Digital Endocrine Disease Management Industry Drivers
- 4.3 Digital Endocrine Disease Management Industry Opportunities and Challenges
- 4.4 Digital Endocrine Disease Management Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Digital Endocrine Disease Management Revenue (2021-2026)
- 5.2 Global Digital Endocrine Disease Management Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Digital Endocrine Disease Management Key Company Headquarters & Area Served
- 5.4 Global Digital Endocrine Disease Management Company, Product Type & Application
- 5.5 Global Digital Endocrine Disease Management Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Digital Endocrine Disease Management Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Digital Endocrine Disease Management Players Market Share by Revenue in 2025
- 5.6.3 2025 Digital Endocrine Disease Management Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Abbott Diabetes Care
- 6.1.1 Abbott Diabetes Care Company Information
- 6.1.2 Abbott Diabetes Care Business Overview
- 6.1.3 Abbott Diabetes Care Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Abbott Diabetes Care Digital Endocrine Disease Management Product Portfolio
- 6.1.5 Abbott Diabetes Care Recent Developments
- 6.2 Dexcom Inc
- 6.2.1 Dexcom Inc Company Information
- 6.2.2 Dexcom Inc Business Overview
- 6.2.3 Dexcom Inc Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Dexcom Inc Digital Endocrine Disease Management Product Portfolio
- 6.2.5 Dexcom Inc Recent Developments
- 6.3 Vida Health
- 6.3.1 Vida Health Company Information
- 6.3.2 Vida Health Business Overview
- 6.3.3 Vida Health Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Vida Health Digital Endocrine Disease Management Product Portfolio
- 6.3.5 Vida Health Recent Developments
- 6.4 Welldoc
- 6.4.1 Welldoc Company Information
- 6.4.2 Welldoc Business Overview
- 6.4.3 Welldoc Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Welldoc Digital Endocrine Disease Management Product Portfolio
- 6.4.5 Welldoc Recent Developments
- 6.5 Lark Health
- 6.5.1 Lark Health Company Information
- 6.5.2 Lark Health Business Overview
- 6.5.3 Lark Health Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Lark Health Digital Endocrine Disease Management Product Portfolio
- 6.5.5 Lark Health Recent Developments
- 6.6 Roche Diabetes Care
- 6.6.1 Roche Diabetes Care Company Information
- 6.6.2 Roche Diabetes Care Business Overview
- 6.6.3 Roche Diabetes Care Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Roche Diabetes Care Digital Endocrine Disease Management Product Portfolio
- 6.6.5 Roche Diabetes Care Recent Developments
- 6.7 Oviva AG
- 6.7.1 Oviva AG Company Information
- 6.7.2 Oviva AG Business Overview
- 6.7.3 Oviva AG Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Oviva AG Digital Endocrine Disease Management Product Portfolio
- 6.7.5 Oviva AG Recent Developments
- 6.8 Kaia Health
- 6.8.1 Kaia Health Company Information
- 6.8.2 Kaia Health Business Overview
- 6.8.3 Kaia Health Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Kaia Health Digital Endocrine Disease Management Product Portfolio
- 6.8.5 Kaia Health Recent Developments
- 6.9 CureApp Inc
- 6.9.1 CureApp Inc Company Information
- 6.9.2 CureApp Inc Business Overview
- 6.9.3 CureApp Inc Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 CureApp Inc Digital Endocrine Disease Management Product Portfolio
- 6.9.5 CureApp Inc Recent Developments
- 6.10 Welby Inc
- 6.10.1 Welby Inc Company Information
- 6.10.2 Welby Inc Business Overview
- 6.10.3 Welby Inc Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Welby Inc Digital Endocrine Disease Management Product Portfolio
- 6.10.5 Welby Inc Recent Developments
- 6.11 Ubie Inc
- 6.11.1 Ubie Inc Company Information
- 6.11.2 Ubie Inc Business Overview
- 6.11.3 Ubie Inc Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Ubie Inc Digital Endocrine Disease Management Product Portfolio
- 6.11.5 Ubie Inc Recent Developments
- 6.12 TeleMed2U
- 6.12.1 TeleMed2U Company Information
- 6.12.2 TeleMed2U Business Overview
- 6.12.3 TeleMed2U Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 TeleMed2U Digital Endocrine Disease Management Product Portfolio
- 6.12.5 TeleMed2U Recent Developments
- 6.13 Twin Health
- 6.13.1 Twin Health Company Information
- 6.13.2 Twin Health Business Overview
- 6.13.3 Twin Health Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Twin Health Digital Endocrine Disease Management Product Portfolio
- 6.13.5 Twin Health Recent Developments
- 6.14 eddii-Care
- 6.14.1 eddii-Care Company Information
- 6.14.2 eddii-Care Business Overview
- 6.14.3 eddii-Care Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 eddii-Care Digital Endocrine Disease Management Product Portfolio
- 6.14.5 eddii-Care Recent Developments
- 6.15 DocVilla
- 6.15.1 DocVilla Company Information
- 6.15.2 DocVilla Business Overview
- 6.15.3 DocVilla Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 DocVilla Digital Endocrine Disease Management Product Portfolio
- 6.15.5 DocVilla Recent Developments
- 6.16 Novo Nordisk Digital Health
- 6.16.1 Novo Nordisk Digital Health Company Information
- 6.16.2 Novo Nordisk Digital Health Business Overview
- 6.16.3 Novo Nordisk Digital Health Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Novo Nordisk Digital Health Digital Endocrine Disease Management Product Portfolio
- 6.16.5 Novo Nordisk Digital Health Recent Developments
- 6.17 Shangyi Technology
- 6.17.1 Shangyi Technology Company Information
- 6.17.2 Shangyi Technology Business Overview
- 6.17.3 Shangyi Technology Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Shangyi Technology Digital Endocrine Disease Management Product Portfolio
- 6.17.5 Shangyi Technology Recent Developments
- 6.18 JD Health
- 6.18.1 JD Health Company Information
- 6.18.2 JD Health Business Overview
- 6.18.3 JD Health Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 JD Health Digital Endocrine Disease Management Product Portfolio
- 6.18.5 JD Health Recent Developments
- 6.19 Alibaba Health
- 6.19.1 Alibaba Health Company Information
- 6.19.2 Alibaba Health Business Overview
- 6.19.3 Alibaba Health Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Alibaba Health Digital Endocrine Disease Management Product Portfolio
- 6.19.5 Alibaba Health Recent Developments
- 6.20 Teladoc Health
- 6.20.1 Teladoc Health Company Information
- 6.20.2 Teladoc Health Business Overview
- 6.20.3 Teladoc Health Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Teladoc Health Digital Endocrine Disease Management Product Portfolio
- 6.20.5 Teladoc Health Recent Developments
- 6.21 Omada Health
- 6.21.1 Omada Health Company Information
- 6.21.2 Omada Health Business Overview
- 6.21.3 Omada Health Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Omada Health Digital Endocrine Disease Management Product Portfolio
- 6.21.5 Omada Health Recent Developments
- 6.22 Virta Health
- 6.22.1 Virta Health Company Information
- 6.22.2 Virta Health Business Overview
- 6.22.3 Virta Health Digital Endocrine Disease Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Virta Health Digital Endocrine Disease Management Product Portfolio
- 6.22.5 Virta Health Recent Developments
7 North America
- 7.1 North America Digital Endocrine Disease Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 7.3 North America Digital Endocrine Disease Management Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Digital Endocrine Disease Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 8.3 Europe Digital Endocrine Disease Management Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Digital Endocrine Disease Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Digital Endocrine Disease Management Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Digital Endocrine Disease Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 10.3 South America Digital Endocrine Disease Management Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Digital Endocrine Disease Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Digital Endocrine Disease Management Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst